Northern RNA

Northern RNA is a Canadian biomanufacturing company based in Calgary, Alberta.

History

Northern RNA was founded on August 19, 2020 by Brad Stevens and Thomas Hansen,[1][2][3] though Stevens' LinkedIn profile suggests the company began work in February 2020.[4]

COVID-19

On January 21, 2021, Northern RNA and Providence Therapeutics received a $5,050,000 grant from the Government of Canada through the Global Innovation Clusters initiative to "develop a made-in-Canada COVID-19 mRNA vaccine" and "establish mRNA vaccine manufacturing capacity within Canada and build a raw material supply chain that supports an exciting new industry."[5]

On January 26, 2021, Providence Therapeutics announced that it had begun Phase I clinical trials for its mRNA COVID-19 vaccine candidate, manufactured in partnership with Northern RNA, which provided the "basic building blocks" of RNA for the product.[3:1][6]

Organization

Name Position Notes
Brad Stevens Co-founder[3:2] City of Calgary, Institute of Corporate Directors (ICD)[7]
Thomas Hansen Co-founder and Vice President[2:1] Calgary Drop-In Centre, American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE), Canadian Network of Asset Managers (CNAM)
Michael Crothers Board Chair Shell
Kevin Appelhof Board member Carbon Controls, International Society of Automation (ISA), Association of Science and Engineering Technology Professionals of Alberta (ASET)
Jared Davis Board member Arcturus Therapeutics, Providence Therapeutics

  1. Northern RNA Inc. Profile. SEDAR. Retrieved July 18, 2023, from http://archive.today/2023.07.18-025138/https://www.sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00052388 ↩︎

  2. Thomas Hansen. Calgary Drop-in Centre. Retrieved July 18, 2023, from https://web.archive.org/web/20230718025503/https://calgarydropin.ca/who-we-are/our-team/thomas-hansen/ ↩︎ ↩︎

  3. Stephenson, A. (2021, January 26). Made-in-Canada COVID vaccine to be manufactured in Calgary; clinical trials have now begun. Calgary Herald. http://archive.today/2021.05.13-174140/https://calgaryherald.com/business/local-business/made-in-canada-covid-vaccine-to-be-manufactured-in-calgary-clinical-trials-have-now-begun ↩︎ ↩︎ ↩︎

  4. Brad Stevens. LinkedIn. Retrieved July 17, 2023, from http://archive.today/2023.07.18-041625/https://www.linkedin.com/in/brad-stevens-13a13223/ ↩︎

  5. Canada’s cluster projects: COVID-19 response. (2022, August 19). Innovation, Science and Economic Development Canada. https://web.archive.org/web/20230706210728/https://ised-isde.canada.ca/site/global-innovation-clusters/en/canadas-cluster-projects-covid-19-response ↩︎

  6. Villani, M. (2021, February 2). Providence Therapeutics seeking federal support for “made-in-Canada” COVID-19 vaccine. CTV News Calgary. http://archive.today/2022.07.11-165610/https://calgary.ctvnews.ca/providence-therapeutics-seeking-federal-support-for-made-in-canada-covid-19-vaccine-1.5292681 ↩︎

  7. Board of Directors. Northern RNA. Retrieved July 18, 2023, from https://web.archive.org/web/20230718030441/https://northernrna.com/board-of-directors/ ↩︎

About the author
Liam Sturgess

Liam Sturgess

Liam Sturgess is a Canadian writer, researcher and investigative reporter focused on issues of human rights and civil liberties, with a particular interest in the COVID-19 pandemic. He is the founder of White Rose Intelligence.

Knowledge is Freedom

Research and intelligence in defense of liberty

White Rose Intelligence

Great! You’ve successfully signed up.

Welcome back! You've successfully signed in.

You've successfully subscribed to White Rose Intelligence.

Success! Check your email for magic link to sign-in.

Success! Your billing info has been updated.

Your billing was not updated.